{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:20:19Z","timestamp":1781108419864,"version":"3.54.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT149087"],"award-info":[{"award-number":["PJT149087"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charles Best Canada Graduate Scholarship Doctoral Award","award":["GSD-159274"],"award-info":[{"award-number":["GSD-159274"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lyme disease (LD) is the most commonly reported vector-borne disease, but its clinical consequences remain uncertain. We conducted a systematic review of the long-term sequelae and health-related quality of life (HRQoL) associated with LD in North America and Europe. We performed searches in 6 electronic databases up to December 2018 following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, including observational studies reporting long-term sequelae, HRQoL, and prognostic factors. We included 46 studies, published between 1994 and 2019. Based on 21 studies reporting attributable outcomes, higher proportions of sequelae reported from exposed patients were: neck pain, myalgia, arthralgia, paresthesia, sleep disorder, poor appetite, and concentration difficulties. Patients with PTLDS reported impaired HRQoL compared to the general US population. Included studies were highly heterogeneous in terms of study design, settings, patient characteristics, and quality. Patients with LD are more likely to report nonspecific long-term sequelae, especially those experiencing persistent symptoms posttreatment. Opportunities exist for prospective longitudinal studies to better understand LD outcomes.<\/jats:p>","DOI":"10.1093\/cid\/ciz1158","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T20:12:48Z","timestamp":1574799168000},"page":"440-452","source":"Crossref","is-referenced-by-count":37,"title":["Long-Term Sequelae and Health-Related Quality of Life Associated With Lyme Disease: A Systematic Review"],"prefix":"10.1093","volume":"71","author":[{"given":"Stephen","family":"Mac","sequence":"first","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada"},{"name":"THETA Collaborative, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Bahia","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Ottawa, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Simbulan","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children (SickKids), Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M","family":"Pullenayegum","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children (SickKids), Toronto, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald A","family":"Evans","sequence":"first","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada"},{"name":"Department of Medicine, Queen\u2019s University, Kingston, Canada"},{"name":"Institute of Clinical Evaluative Sciences, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir N","family":"Patel","sequence":"first","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Sander","sequence":"first","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada"},{"name":"THETA Collaborative, University Health Network, Toronto, Canada"},{"name":"Institute of Clinical Evaluative Sciences, Toronto, Canada"},{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"2020071109150060400_CIT0001","first-page":"1724","volume-title":"N Engl J Med","author":"Shapiro","year":"2014"},{"key":"2020071109150060400_CIT0002","first-page":"461","article-title":"Lyme borreliosis","volume-title":"Lancet","author":"Stanek","year":"2012"},{"key":"2020071109150060400_CIT0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease.","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"2020071109150060400_CIT0004","author":"Centers for Disease Control and Prevention.","year":"2017"},{"key":"2020071109150060400_CIT0005","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes","year":"2016","journal-title":"J Public Health"},{"key":"2020071109150060400_CIT0006","author":"Public Health Agency of Canada.","year":"2018"},{"key":"2020071109150060400_CIT0007","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020071109150060400_CIT0008","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1503\/cmaj.080148","article-title":"The emergence of Lyme disease in Canada","volume":"180","author":"Ogden","year":"2009","journal-title":"CMAJ"},{"key":"2020071109150060400_CIT0009","author":"Centers for Disease Control and Prevention"},{"key":"2020071109150060400_CIT0010","first-page":"255","article-title":"Lyme carditis","volume-title":"Infect Dis Clin N Am","author":"Robinson","year":"2015"},{"key":"2020071109150060400_CIT0011","first-page":"309","article-title":"Posttreatment Lyme disease syndrome","volume-title":"Infect Dis Clin N Am","author":"Aucott","year":"2015"},{"key":"2020071109150060400_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","article-title":"Measurement of health state utilities for economic appraisal: a review","volume":"5","author":"Torrance","year":"1986","journal-title":"J Health Econ"},{"key":"2020071109150060400_CIT0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2020071109150060400_CIT0014","author":"Statistics Canada","year":"2013"},{"key":"2020071109150060400_CIT0015","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1017\/S0031182003004694","article-title":"Lyme borreliosis in Europe and North America","volume":"129","author":"Piesman","year":"2004","journal-title":"Parasitology"},{"key":"2020071109150060400_CIT0016","author":"The Joanna Briggs Institute.","year":"2017"},{"key":"2020071109150060400_CIT0017"},{"key":"2020071109150060400_CIT0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jclinepi.2017.04.019","article-title":"Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences\u2019 studies","volume":"85","author":"Yepes-Nu\u00f1ez","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2020071109150060400_CIT0019","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1473-3099(15)00134-6","article-title":"Long-term sequelae of West Nile virus-related illness: a systematic review","volume":"15","author":"Patel","journal-title":"Lancet Infect Dis"},{"key":"2020071109150060400_CIT0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10\u201320-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J Infect Dis"},{"key":"2020071109150060400_CIT0021","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/eurpub\/ckv091","article-title":"The burden of Lyme borreliosis expressed in disability-adjusted life years","volume":"25","author":"van den Wijngaard","year":"2015","journal-title":"Eur J Public Health"},{"key":"2020071109150060400_CIT0022","first-page":"e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease","volume-title":"Pediatrics","author":"Vazquez","year":"2003"},{"key":"2020071109150060400_CIT0023","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","article-title":"Lyme neuroborreliosis in children a prospective study of clinical features, prognosis, and outcome","volume":"27","author":"Skogman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2020071109150060400_CIT0024","first-page":"2249","article-title":"Outcomes of children treated for Lyme disease","volume":"25","author":"Wang","year":"1998","journal-title":"J Rheumatogy"},{"key":"2020071109150060400_CIT0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1176\/jnp.13.4.500","article-title":"A controlled study of cognitive deficits in children with chronic Lyme disease","volume":"13","author":"Tager","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2020071109150060400_CIT0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2334-10-20","article-title":"Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis","volume":"10","author":"Tjernberg","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2020071109150060400_CIT0027","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/ciw189","article-title":"Long-term follow-up of patients with Lyme disease: longitudinal analysis of clinical and quality-of-life measures","volume":"62","author":"Wills","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020071109150060400_CIT0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1542\/peds.94.2.185","article-title":"Cognitive effects of Lyme disease in children","volume":"94","author":"Adams","year":"1994","journal-title":"Pediatrics"},{"key":"2020071109150060400_CIT0029","first-page":"1190","article-title":"Cognitive effects of Lyme disease in children: a 4 year followup study","volume":"26","author":"Adams","year":"1999","journal-title":"J Rheumatogy"},{"key":"2020071109150060400_CIT0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/civ277","article-title":"Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease","volume":"61","author":"Wormser","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020071109150060400_CIT0031","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0033-1349724","article-title":"Neuropsychological profile of children after an episode of neuroborreliosis","volume":"44","author":"Zotter","year":"2013","journal-title":"Neuropediatrics"},{"key":"2020071109150060400_CIT0032","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199707313370525","article-title":"Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis","volume":"337","author":"Eckman","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071109150060400_CIT0033","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00415-015-7891-4","article-title":"Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis","volume":"262","author":"Dersch","year":"2015","journal-title":"J Neurol"},{"key":"2020071109150060400_CIT0034","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0896-6974(97)00105-9","article-title":"Symptoms of psychiatric disturbance in epilepsy","volume":"11","author":"Ettinger","year":"1998","journal-title":"J Epilepsy"},{"key":"2020071109150060400_CIT0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"key":"2020071109150060400_CIT0036","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00415-013-6831-4","article-title":"Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life","volume":"260","author":"Back","year":"2013","journal-title":"J Neurol"},{"key":"2020071109150060400_CIT0037","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.510230617","article-title":"Liver function in early Lyme disease","volume":"23","author":"Horowitz","year":"1996","journal-title":"Hepatology"},{"key":"2020071109150060400_CIT0038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1207\/s15324826an0601_1","article-title":"Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology","volume":"6","author":"Kaplan","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"2020071109150060400_CIT0039","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1529-0131(199902)12:1<42::AID-ART7>3.0.CO;2-3","article-title":"The fibromyalgia impact questionnaire: a useful tool in evaluating patients with post-Lyme disease syndrome","volume":"12","author":"Fallon","year":"1999","journal-title":"Arthritis Care Res"},{"key":"2020071109150060400_CIT0040","first-page":"912","article-title":"Sleep quality in Lyme disease","volume":"18","author":"Greenberg","year":"1995","journal-title":"Sleep"},{"key":"2020071109150060400_CIT0041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1207\/s15324826an0601_4","article-title":"Does process-specific slowing account for cognitive deficits in Lyme disease?","volume":"6","author":"Pollina","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"2020071109150060400_CIT0042","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-128-5-199803010-00002","article-title":"Lack of cardiac manifestations among patients with previously treated Lyme disease","volume":"128","author":"Sangha","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020071109150060400_CIT0043","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-128-1-199801010-00007","article-title":"Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis.","volume":"128","author":"Nichol","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020071109150060400_CIT0044","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1355617706060231","article-title":"WAIS-III and WMS-III performance in chronic Lyme disease","volume":"12","author":"Keilp","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"2020071109150060400_CIT0045","first-page":"72","article-title":"Cognitive processing speed in Lyme disease","volume":"12","author":"Pollina","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"2020071109150060400_CIT0046","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"key":"2020071109150060400_CIT0047","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071109150060400_CIT0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0386-1","article-title":"Neurocognitive functions and brain atrophy after proven neuroborreliosis: a case-control study","volume":"15","author":"Schmidt","year":"2015","journal-title":"BMC Neurol"},{"key":"2020071109150060400_CIT0049","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/arclin\/acy083","article-title":"Neurocognition in post-treatment Lyme disease and major depressive disorder","volume":"34","author":"Keilp","year":"2019","journal-title":"Arch Clin Neuropsychol"},{"key":"2020071109150060400_CIT0050","first-page":"1","article-title":"Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study","volume":"361","author":"Obel","year":"2018","journal-title":"BMJ"},{"key":"2020071109150060400_CIT0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"2020071109150060400_CIT0052","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/cid\/cix605","article-title":"Depressive symptoms in patients referred to a tertiary Lyme center: high prevalence in those without evidence of Lyme borreliosis","volume":"65","author":"Zomer","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020071109150060400_CIT0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0195260","article-title":"Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease","volume":"13","author":"Berende","year":"2018","journal-title":"PLoS One"},{"key":"2020071109150060400_CIT0054","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ttbdis.2013.09.002","article-title":"Functional outcomes in patients with Borrelia burgdorferi reinfection","volume":"5","author":"Jares","year":"2014","journal-title":"Ticks Tick Borne Dis"},{"key":"2020071109150060400_CIT0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-018-1163-2","article-title":"Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome: a prospective cohort study","volume":"18","author":"Backman","year":"2018","journal-title":"BMC Pediatr"},{"key":"2020071109150060400_CIT0056","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamadermatol.2018.2306","article-title":"Comparison of clinical course and treatment outcome for patients with early disseminated or early localized Lyme borreliosis","volume":"154","author":"Stupica","year":"2018","journal-title":"JAMA Dermatology"},{"key":"2020071109150060400_CIT0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsy035","article-title":"Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland","volume":"41","author":"Weinstein","year":"2018","journal-title":"Sleep"},{"key":"2020071109150060400_CIT0058","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/jac\/dkx534","article-title":"Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial","volume":"73","author":"Stupica","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020071109150060400_CIT0059","first-page":"5","article-title":"Evaluation of prospectively followed adult patients with erythema migrans using the beck depression inventory second edition","author":"Wormser","year":"2019","journal-title":"Am J Med"},{"key":"2020071109150060400_CIT0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.psym.2018.02.004","article-title":"Depressive symptoms and suicidal ideation among symptomatic patients with a history of Lyme disease vs two comparison groups","volume":"59","author":"Doshi","year":"2018","journal-title":"Psychosomatics"},{"key":"2020071109150060400_CIT0061","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.161.4.554","article-title":"The cost-effectiveness of vaccination against Lyme disease","volume":"161","author":"Shadick","year":"2001","journal-title":"Arch Intern Med"},{"key":"2020071109150060400_CIT0062","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"key":"2020071109150060400_CIT0063","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1542\/peds.2011-3719","article-title":"Long-term clinical outcome after Lyme neuroborreliosis in childhood","volume":"130","author":"Skogman","year":"2012","journal-title":"Pediatrics"},{"key":"2020071109150060400_CIT0064","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1207\/s15324826an0601_5","article-title":"The neuropsychological examination of naming in Lyme borreliosis","volume":"6","author":"Svetina","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"2020071109150060400_CIT0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.AUD.0000100205.25774.5F","article-title":"Audiologic manifestations of patients with post-treatment Lyme disease syndrome","volume":"24","author":"Shotland","year":"2003","journal-title":"Ear Hear"},{"key":"2020071109150060400_CIT0066","first-page":"832","article-title":"What are the most common conditions in primary care? Systematic review","volume":"64","author":"Finley","year":"2018","journal-title":"Can Fam Physician"},{"key":"2020071109150060400_CIT0067","doi-asserted-by":"crossref","first-page":"e0198509","DOI":"10.1371\/journal.pone.0198509","article-title":"Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005\u20132014","volume":"13","author":"Johnson","year":"2018","journal-title":"PLoS One"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz1158\/32970393\/ciz1158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/2\/440\/33486108\/ciz1158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/2\/440\/33486108\/ciz1158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T23:48:30Z","timestamp":1665100110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/2\/440\/5644106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,27]]},"published-print":{"date-parts":[[2020,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz1158","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7,15]]},"published":{"date-parts":[[2019,11,27]]}}}